A primary focus during the early stages of research and development is to minimize future risk. Our comprehensive solution ensures consistent quality from compound optimization and preclinical work through clinical-study sample collection and analysis. Our experience executing protein-binding studies coupled with the application of larger capacity, automated formats delivers high-quality, timely data at excellent value.

  • Automated processing
  • Custom-built equilibrium dialysis device (500 µL volume) or other commercial plate-based systems
  • Equilibrium dialysis
  • Radioactive or non-radioactive compounds
  • Ultracentrifugation
  • Ultrafiltration